Northern Trust
DERM icon

Northern Trust’s Journey Medical DERM Stock Holding History

Northern Trust’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Sell
35,656
-114,322
-76% -$653K ﹤0.01% 3865
2026
Q1 		$703K Buy
149,978
+56,309
+60% +$437K ﹤0.01% 3480
2025
Q4 		$722K Buy
93,669
+927
+1% +$7.27K ﹤0.01% 3516
2025
Q3 		$660K Buy
92,742
+7,750
+9% +$56.2K ﹤0.01% 3555
2025
Q2 		$610K Buy
84,992
+67,733
+392% +$468K ﹤0.01% 3590
2025
Q1 		$102K Hold
17,259
– – ﹤0.01% 4110
2024
Q4 		$67.5K Sell
17,259
-395
-2% -$2.16K ﹤0.01% 4220
2024
Q3 		$99.7K Hold
17,654
– – ﹤0.01% 4056
2024
Q2 		$99.6K Hold
17,654
– – ﹤0.01% 4056
2024
Q1 		$65K Buy
17,654
+1,000
+6% +$4.35K ﹤0.01% 4181
2023
Q4 		$95.9K Buy
+16,654
New +$74.2K ﹤0.01% 4124

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Northern Trust's DERM Position: Q2 2026 in Review

Northern Trust reduced its Journey Medical (DERM) stake by 76% in Q2 2026, selling an estimated $653K and leaving 35,656 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #3865.

Northern Trust first reported a position in DERM in Q4 2023 and has held it in 11 quarters since. The position peaked at $722K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Northern Trust held 35,656 shares of Journey Medical worth $252K as of Q2 2026.
  • Northern Trust sold 114,322 Journey Medical shares in Q2 2026, an estimated $653K.
  • Journey Medical made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3865 holding.
  • Northern Trust first reported a position in Journey Medical in Q4 2023 and has held it in 11 quarters since.
  • Northern Trust's Journey Medical position peaked at $722K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.